Cryptosporidiosis diagnosed using metagenomic next-generation sequencing in a healthy child admitted to pediatric intensive care unit: a case report
- PMID: 37965251
- PMCID: PMC10641789
- DOI: 10.3389/fcimb.2023.1269963
Cryptosporidiosis diagnosed using metagenomic next-generation sequencing in a healthy child admitted to pediatric intensive care unit: a case report
Abstract
Background: Cryptosporidium infections in humans typically result in symptoms such as abdominal pain and diarrhea. When the diarrhea is severe, it can cause serious complications and even be life-threatening, especially in patients with compromised immune systems.
Case presentation: Here, we reported the use of metagenomic next-generation sequencing (mNGS) to assist in the diagnosis and treatment of a 10-year-old boy with severe Cryptosporidium infection. Despite the absence of any history of immunocompromise, the infection still resulted in severe symptoms, including shock, as well as damage to his pancreas and kidneys. The mNGS tests detected the presence of Cryptosporidium parvum when conventional methods failed. The patient received anti-parasite treatment along with supportive care to manage the condition. With disease surveillance based on regular clinical tests and sequential mNGS tests, the child recovered from the severe conditions.
Conclusion: Our study emphasized the importance of recognizing the potential severity of Cryptosporidium infection, even among individuals with normal immune systems. Timely diagnosis and ongoing monitoring are essential for patient prognosis.
Keywords: Cryptosporidium parvum; PICU; healthy boy; mNGS; pancreatitis.
Copyright © 2023 Liu, Wang, Liu, Li, Guan, Qian and Jia.
Conflict of interest statement
JW, XML, and YG were employed by Hugobiotech Co., Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Case Report: Severe Diarrhea Caused by Cryptosporidium Diagnosed by Metagenome Next-Generation Sequencing in Blood.Infect Drug Resist. 2023 Sep 1;16:5777-5782. doi: 10.2147/IDR.S422799. eCollection 2023. Infect Drug Resist. 2023. PMID: 37675126 Free PMC article.
-
Utilizing metagenomic next-generation sequencing for diagnosis and lung microbiome probing of pediatric pneumonia through bronchoalveolar lavage fluid in pediatric intensive care unit: results from a large real-world cohort.Front Cell Infect Microbiol. 2023 Aug 15;13:1200806. doi: 10.3389/fcimb.2023.1200806. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37655299 Free PMC article.
-
Cryptosporidium species from human immunodeficiency-infected patients with chronic diarrhea in Jakarta, Indonesia.Ann Epidemiol. 2013 Nov;23(11):720-3. doi: 10.1016/j.annepidem.2013.07.019. Epub 2013 Aug 23. Ann Epidemiol. 2013. PMID: 23972618
-
Widespread occurrence of Cryptosporidium infections in patients with HIV/AIDS: Epidemiology, clinical feature, diagnosis, and therapy.Acta Trop. 2018 Nov;187:257-263. doi: 10.1016/j.actatropica.2018.08.018. Epub 2018 Aug 15. Acta Trop. 2018. PMID: 30118699 Review.
-
Epidemiology of Cryptosporidium in Pediatric Diarrheal Illnesses.Indian Pediatr. 2017 Apr 15;54(4):299-309. doi: 10.1007/s13312-017-1093-3. Indian Pediatr. 2017. PMID: 28474590 Review.
Cited by
-
Infection of Enterocytozoon bieneusi in a Patient with Long-Term Immunosuppression after Liver Transplantation: A Case Report and Literature Review.Case Rep Gastroenterol. 2025 Aug 8;19(1):556-567. doi: 10.1159/000546660. eCollection 2025 Jan-Dec. Case Rep Gastroenterol. 2025. PMID: 40786849 Free PMC article.
-
Application of metagenomic next-generation sequencing in the diagnosis of infectious diseases.Front Cell Infect Microbiol. 2024 Nov 15;14:1458316. doi: 10.3389/fcimb.2024.1458316. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39619659 Free PMC article. Review.
References
-
- Abouel-Nour M. F., El-Shewehy D. M., Hamada S. F., Morsy T. A. (2016). The efficacy of three medicinal plants; garlic, ginger and mirazid and a chemical drug metronidazole against cryptosporidium parvum: ii-histological changes. J. Egypt Soc. Parasitol. 46 (1), 185–200. doi: 10.12816/0026164 - DOI - PubMed
-
- Agnamey P., Sarfati C., Pinel C., Rabodoniriina M., Kapel N., Dutoit E., et al. . (2011). Evaluation of four commercial rapid immunochromatographic assays for detection of Cryptosporidium antigens in stool samples: a blind multicenter trial. J. Clin. Microbiol. 49 (4), 1605–1607. doi: 10.1128/jcm.02074-10 - DOI - PMC - PubMed
-
- Ai J. W., Zhang H. C., Cui P., Xu B., Gao Y., Cheng Q., et al. . (2018). Dynamic and direct pathogen load surveillance to monitor disease progression and therapeutic efficacy in central nervous system infection using a novel semi-quantitive sequencing platform. J. Infect. 76 (3), 307–310. doi: 10.1016/j.jinf.2017.11.002 - DOI - PubMed